Class II
Drug Recall: Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore Maryland, Manufactured by: Lupin Limited,
Lupin Pharmaceuticals Inc. · May 30, 2024
Reason for Recall
Failed Content Uniformity Specifications
Product Description
Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore Maryland, Manufactured by: Lupin Limited, Mandideep, India NDC 68180-407-03
Distribution
Nationwide in the US
States Affected
NATIONWIDE
Quantity Affected
3,552 bottles
Source: FDA (openFDA Drug Enforcement)
Recall number: D-0559-2024
Status: terminated
SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.